Patents are the wrong vehicle here. Patents are merely a license to monetize and exclude other from these innovations. Standards is where the greater good lie.
(The patents and empty delivery vessel supply chain should be originated and owned by FDA and made available under FRAND condititions, not counting the existing fees charged to the pharmaceutical industry.)
